Benefits of Selling a Structured Settlement
A structured settlement may seem like a good option when you win your personal injury lawsuit. After all, what could be better than regular, tax-free payments to cover your bills, right? However, some plaintiffs find after a structured settlement is negotiated that periodic payments don’t cover all the bills that add up after a catastrophic injury. Medical bills may continue… Read more »
GM Recall Settlement Funding Provides Safety Net for Plaintiffs
GM has just been pounded with a $10 billion class action lawsuit alleging that its well-documented ignition switch recall problems are hurting the resale value of millions of GM vehicles. The lawsuit claims that GM should compensate 15 million vehicle owners for diminished resale value due to the recalls and the publicity surrounding the growing number of personal injury lawsuits… Read more »
Risk-Free Talc Powder Lawsuit Funding Available
Litigation is heating up amid claims and research showing that genital use of talc-based products such as Johnson & Johnson’s trademarked Shower-to-Shower and Baby Powder is linked to ovarian cancer. One Harvard epidemiologist, who provided testimony in a recent talc cancer lawsuit, has speculated that as many as 10,000 American women are diagnosed with ovarian cancer every year due to… Read more »
Low T Drug Lawsuit Funding Available Now
Lawsuits involving serious side effects associated with testosterone therapy drugs have now been centralized in federal court. Multidistrict litigation has been established in U.S. District Court for the Northern District of Illinois in order to streamline early trial proceedings for a growing number of cases. Despite coordination efforts, plaintiffs who have filed these lawsuits may find low T drug lawsuit… Read more »
Boehringer Ingelheim Agrees to Pay $650M to Settle Pradaxa Lawsuits
Earlier this week, Boehringer Ingelheim – the German-based manufacturer of the blood thinner Pradaxa – agreed to pay $650 million to resolve litigation arising from Pradaxa-related bleeding incidents. The settlement will resolve an estimated 4,000 personal injury lawsuits pending against the company in Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation, MDL No. 2385 as well as in several state courts…. Read more »
